These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9820514)

  • 1. Attenuation of inducible Th2 immunity with autoimmune disease progression.
    Tian J; Kaufman DL
    J Immunol; 1998 Nov; 161(10):5399-403. PubMed ID: 9820514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
    Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
    J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
    Tisch R; Wang B; Serreze DV
    J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice.
    Olcott AP; Tian J; Walker V; Dang H; Middleton B; Adorini L; Washburn L; Kaufman DL
    J Immunol; 2005 Aug; 175(3):1991-9. PubMed ID: 16034144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease prevention with islet autoantigens.
    Eisenbarth GS; Jasinski JM
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):59-73, viii. PubMed ID: 15053895
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
    Lejon K; Fathman CG
    J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in pre-diabetic mice.
    Tian J; Chau C; Kaufman DL
    Diabetologia; 1998 Feb; 41(2):237-40. PubMed ID: 9498660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-based immunotherapy drives the precocious development of autoimmunity.
    Tian J; Olcott AP; Kaufman DL
    J Immunol; 2002 Dec; 169(11):6564-9. PubMed ID: 12444168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
    Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells.
    Kumar V; Sercarz E
    J Immunol; 1998 Dec; 161(12):6585-91. PubMed ID: 9862685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
    Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ
    Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.
    Hong S; Wilson MT; Serizawa I; Wu L; Singh N; Naidenko OV; Miura T; Haba T; Scherer DC; Wei J; Kronenberg M; Koezuka Y; Van Kaer L
    Nat Med; 2001 Sep; 7(9):1052-6. PubMed ID: 11533710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens.
    Tian J; Lehmann PV; Kaufman DL
    J Exp Med; 1997 Dec; 186(12):2039-43. PubMed ID: 9396773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice.
    Mizuno M; Masumura M; Tomi C; Chiba A; Oki S; Yamamura T; Miyake S
    J Autoimmun; 2004 Dec; 23(4):293-300. PubMed ID: 15571923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
    Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
    J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.
    Falcone M; Yeung B; Tucker L; Rodriguez E; Krahl T; Sarvetnick N
    Clin Immunol; 2001 Feb; 98(2):190-9. PubMed ID: 11161975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles.
    Han G; Wang R; Chen G; Wang J; Xu R; Feng J; Yu M; Wu X; Qian J; Shen B; Li Y
    Immunol Lett; 2008 Jan; 115(2):110-6. PubMed ID: 18045698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.